Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Prinses Máxima Centrum Voorpagina
Nederlands
English
Voorpagina
Profielen
Onderzoeksgroepen
Uitrusting
Onderzoeksoutput
Prijzen
Activiteiten
Knipsels
Zoeken op expertise, naam of affiliatie
Immunophenotyping as a guide for targeted therapy
Pieter Sonneveld,
Rob Pieters
Onderzoeksoutput
:
Bijdrage aan tijdschrift
›
Artikel
›
peer review
6
Citaten (Scopus)
Overzicht
Vingerafdruk
Vingerafdruk
Duik in de onderzoeksthema's van 'Immunophenotyping as a guide for targeted therapy'. Samen vormen ze een unieke vingerafdruk.
Sorteer per
Gewicht
Alfabetische volgorde
Keyphrases
Targeted Therapy
100%
Immunophenotyping
100%
Specific Antigen
100%
Antigen Expression
50%
Clinical Trials
25%
Clinical Benefit
25%
Refractory Disease
25%
Expression Pattern
25%
Clinical Prognosis
25%
Leukemia
25%
Acute Myeloid Leukemia
25%
Prognostic Relevance
25%
Acute Leukemia
25%
Further Development
25%
Disease-specific
25%
Clinical Activity
25%
Poor Response
25%
Relapsed or Refractory Acute Myeloid Leukemia
25%
Tyrosine Kinase
25%
Multidrug Resistance Protein
25%
CD33
25%
Response to Treatment
25%
Leukaemic Cells
25%
Chronic Lymphocytic Leukemia
25%
Graves
25%
Imatinib
25%
FLT3 Inhibitor
25%
P-glycoprotein Inhibitor
25%
New Agents
25%
Tumor-targeted Therapy
25%
ATP-binding Cassette Transporter A1 (ABCA1)
25%
Therapeutic Relevance
25%
New Leads
25%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Acute Myeloid Leukemia
100%
Clinical Trial
50%
Neoplasm
50%
Acute Leukemia
50%
Leukemia
50%
Protein Tyrosine Kinase
50%
CD33 Antigen
50%
P-Glycoprotein
50%
Imatinib
50%
Glycoprotein P Inhibitor
50%
ABC Transporter
50%
Chronic Leukemia
50%
Medicine and Dentistry
Targeted Therapy
100%
Immunophenotyping
100%
Antigen Specificity
100%
Disease
50%
Acute Myeloid Leukemia
50%
Clinical Trial
25%
Leukemia
25%
Specific Tumor
25%
Acute Leukemia
25%
Protein Tyrosine Kinase
25%
ABC Transporter Subfamily B
25%
Antigen Expression
25%
Imatinib
25%
CD33 Antigen
25%
ABC Transporter
25%
Glycoprotein P Inhibitor
25%
Chronic Leukemia
25%
Immunology and Microbiology
Antigen Specificity
100%
Myeloid
75%
Lineages
50%
P-Glycoprotein
50%
CD33 Antigen
25%
Antigen Expression
25%
ABC Transporter
25%
Immunology
25%